Protocol summary

Study aim
Comparison of the effect of administration of midazolam and ketorolac compared to administration of morphine and ketorolac on pain relief in renal colic patients referred to the emergency room
Design
A two-group, parallel-group, triple-blind, randomized, phase 3 clinical trial on 200 patients. The rand function of Excel software will be used for randomization.
Settings and conduct
The emergency department of Khatam Al-Anbia Hospital, Zahedan, will be the location of the research; After the patient enters the study, the patient's level of sedation will be evaluated by Ramsey's criteria, and two sets of drugs will be prescribed for patients in groups A and B. Pain scores, sedation, hemodynamic parameters, and side effects in the next 20, 40, 60, and 90 minutes. They will be registered from the intervention. The study is three-way blind.
Participants/Inclusion and exclusion criteria
Inclusion: 1- Men or women will be 15 to 75 years old, who will be diagnosed with acute renal colic. 2- They will get a score of 4 or higher on the visual analog scale (VAS). 3-stable in terms of hemodynamics (based on initial triage) 4- Consent of patients or patients' companions to enter the study Exclusion: 1- Allergy to morphine, ketorolac or midazolam 2- Intravenous analgesic consumption in the past 4 hours 3- Drug addiction 4- Pregnancy and breastfeeding
Intervention groups
The first group will receive 30 mg of intravenous ketorolac within one minute and 5 mg of intravenous morphine (in a volume of 5 cc) within five minutes, and the second group will receive 30 mg of intravenous ketorolac within one minute and 2 mg of intravenous midazolam.
Main outcome variables
Renal colic pain; Level of sedation; Percentage of oxygen saturation; Breathing rate

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220516054869N5
Registration date: 2024-11-10, 1403/08/20
Registration timing: prospective

Last update: 2024-11-10, 1403/08/20
Update count: 0
Registration date
2024-11-10, 1403/08/20
Registrant information
Name
ali abdolrazaghnejad
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 54 3323 2890
Email address
ali.abdolrazaghnejad@zaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2025-03-20, 1403/12/30
Expected recruitment end date
2025-05-20, 1404/02/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effect of prescribing midazolam and ketorolac in comparison with prescribing morphine and ketorolac on the pain relief of renal colic patients referred to the emergency department of Khatam al-Anbia in Zahedan in 2025
Public title
The effect of administration of midazolam and ketorolac in comparison with administration of morphine and ketorolac on pain relief in patients with renal colic
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Men or women will be 15 to 75 years old, who will be diagnosed with acute renal colic by radiography or ultrasound (based on the opinion of the emergency medicine doctor) They will get a score of 4 or higher on the visual analog scale (VAS). Hemodynamically stable (based on initial triage) Consent of patients or patients' companions to enter the study
Exclusion criteria:
Allergy to morphine, ketorolac or midazolam Renal dysfunction (according to GFR and BUN, Cr) Having one kidney or a history of kidney transplant Intravenous painkiller was consumed in 4 hours Paralytic ileus Heart failure due to chronic lung disease Convulsive disorders, acute respiratory failure Acute angle-closure glaucoma Severe low blood pressure or shock History of allergy to other NSAIDS Hemorrhagic disease Having coagulation disorders (or taking warfarin) Having vascular and cerebral lesions Having underlying diseases such as mental disorders, having fibromyalgia, cardiovascular disease, digestive diseases Drug addiction Pregnancy and breastfeeding
Age
From 15 years old to 75 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Data analyser
Sample size
Target sample size: 200
Randomization (investigator's opinion)
Randomized
Randomization description
Random assignment of patients to two groups is done by permuted block stratified randomization method. In this way, first, eligible referring patients are classified according to age (15-30, 31-45, 46-60 and 75-61) in the order of entry. Then, they are assigned to the desired group based on blocks of 4 (consisting of two groups A and B and two repetitions for each) randomly selected from among all possible states of permutations. These blocks were created using statistical software R version 4.0.2.
Blinding (investigator's opinion)
Triple blinded
Blinding description
In order to establish randomization and comply with the conditions of blinding, two combination packages of Ketorolac-morphine and Ketorolac-midazolam drugs are brought to the same volume and the surface of the syringes are covered and coded with A-B and C-D labels and placed in 200 numbered envelopes. and provided to the researcher.He also opens the envelopes according to the patient's choice and administers the desired prescription. In this way, the interventions were carried out in completely randomized conditions and the researcher will not know the type of intervention in each group. Also, the patient does not know the type of medicine received. At the end, the statistician will perform the necessary analysis without knowing the type of intervention in each group, and finally the name of each group will be announced by the nurse who prepares the medicine packages.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Zahedan University of Medical Sciences
Street address
Persian Gulf Boulevard; Zahedan University of Medical Sciences
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Approval date
2024-10-12, 1403/07/21
Ethics committee reference number
IR.ZAUMS.REC.1403.286

Health conditions studied

1

Description of health condition studied
Pain management of renal colic patients
ICD-10 code
G89.1
ICD-10 code description
Acute pain, not elsewhere classified

Primary outcomes

1

Description
Renal colic pain
Timepoint
At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Visual analog scale

2

Description
Level of sedation
Timepoint
At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Ramsay criterion

3

Description
Oxygen saturation percentage
Timepoint
At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Pulse oximetry device

4

Description
Respiratory rate
Timepoint
At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Counting by the nurse

Secondary outcomes

1

Description
Headache
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Having or not having a side effect after the intervention

2

Description
Hypotension or hypertension
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Pressure gauge device

3

Description
Dizziness
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Having or not having a side effect after the intervention

4

Description
Sleepiness
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Having or not having a side effect after the intervention

5

Description
Decreased tendon reflex
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Having or not having a side effect after the intervention

6

Description
Arrhythmia (tachycardia, bradycardia)
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Observation in monitoring

7

Description
Skin lesions
Timepoint
At 20, 40, 60 and 90 minutes after the intervention
Method of measurement
Observation

Intervention groups

1

Description
Intervention group: In the first group, 30 mg of intravenous ketorolac will be administered within one minute and 5 mg of intravenous morphine (in a volume of 5 cc) will be prescribed within five minutes.
Category
Treatment - Drugs

2

Description
Intervention group: In the second group, 30 mg of intravenous ketorolac will be administered within one minute and 2 mg of intravenous midazolam.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Khatam Al Anbia Hospital, Zahedan
Full name of responsible person
Ali Abdolrazaghnejad
Street address
Zahedan, Khatam al-Anbia square
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Phone
+98 54 3223 2890
Email
ali.abdorazzagh@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Ebrahim Kord
Street address
Persian Gulf Blvd., Zahedan Pareshki University of Sciences, Central Headquarters
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Phone
+98 54 3323 2890
Email
ali.abdorazzagh@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Zahedan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Ali Abdolrazaghnejad
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Persian Gulf Boulevard, Zahedan University of Medical Sciences, Faculty of Medicine
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Phone
+98 54 3323 2890
Email
ali.abdorazzagh@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Ali Abdolrazaghnejad
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Persian Gulf Boulevard, Zahedan University of Medical Sciences, Faculty of Medicine
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Phone
+98 54 3323 2890
Email
ali.abdorazzagh@gamil.com

Person responsible for updating data

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Ali Abdolrazaghnejad
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Persian Gulf Boulevard, Zahedan University of Medical Sciences, Faculty of Medicine
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9815733169
Phone
+98 54 3323 2890
Email
ali.abdolrazaghnejad@zaums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All data can be shared after de-identifying individuals.
When the data will become available and for how long
Access starts one year after results are published
To whom data/document is available
Researchers working in academic and scientific institutions
Under which criteria data/document could be used
The use of documents for research exploitations in the field of drug therapy is unimpeded only for researchers.
From where data/document is obtainable
Correspondence with the email address ali.abdolrazaghnejad@zaumas.ac.ir.
What processes are involved for a request to access data/document
After sending the applicant's application and receiving the email, if the applicant is eligible, the data files will be sent to the email address.
Comments
Loading...